Trial Outcomes & Findings for Improving Goals of Care Discussion in Advanced Cancer Patients (NCT NCT02374255)
NCT ID: NCT02374255
Last Updated: 2019-10-01
Results Overview
Number of patient's perceptions that goals of care discussions were increased occurred as measured by GoC qualitative patient survey.
COMPLETED
NA
265 participants
up to 6 months
2019-10-01
Participant Flow
Oncologists were not considered enrolled into the study.
Participant milestones
| Measure |
Patients - GoC Intervention
Patients given OncoTalk GoC intervention
GoC intervention: Training of oncologists using OncoTalk to conduct Goals of Care discussions and measure impact on patient satisfaction.
|
Patients - Usual Care
Prospective control group where no intervention was given.
|
Oncologists - GoC Intervention
Oncologists trained using OncoTalk to have Goals of Care discussions.
|
Oncologists - Usual Care
Oncologists not trained using OncoTalk to have Goals of Care discussions.
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
155
|
110
|
11
|
11
|
|
Overall Study
COMPLETED
|
153
|
110
|
11
|
11
|
|
Overall Study
NOT COMPLETED
|
2
|
0
|
0
|
0
|
Reasons for withdrawal
| Measure |
Patients - GoC Intervention
Patients given OncoTalk GoC intervention
GoC intervention: Training of oncologists using OncoTalk to conduct Goals of Care discussions and measure impact on patient satisfaction.
|
Patients - Usual Care
Prospective control group where no intervention was given.
|
Oncologists - GoC Intervention
Oncologists trained using OncoTalk to have Goals of Care discussions.
|
Oncologists - Usual Care
Oncologists not trained using OncoTalk to have Goals of Care discussions.
|
|---|---|---|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
0
|
0
|
0
|
Baseline Characteristics
Improving Goals of Care Discussion in Advanced Cancer Patients
Baseline characteristics by cohort
| Measure |
Patients - GoC Intervention
n=155 Participants
Patients given OncoTalk GoC intervention
GoC intervention: Training of oncologists using OncoTalk to conduct Goals of Care discussions and measure impact on patient satisfaction.
|
Patients - Usual Care
n=110 Participants
Prospective control group where no intervention was given.
|
Oncologists - GoC Intervention
Oncologists trained using OncoTalk to have Goals of Care discussions.
|
Oncologists - Usual Care
Oncologists not trained using OncoTalk to have Goals of Care discussions.
|
Total
n=265 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
|
63 years
STANDARD_DEVIATION 12.3 • n=5 Participants
|
65 years
STANDARD_DEVIATION 11.3 • n=7 Participants
|
—
|
—
|
64 years
STANDARD_DEVIATION 11.8 • n=21 Participants
|
|
Sex: Female, Male
Female
|
64 Participants
n=5 Participants
|
44 Participants
n=7 Participants
|
—
|
—
|
108 Participants
n=21 Participants
|
|
Sex: Female, Male
Male
|
91 Participants
n=5 Participants
|
66 Participants
n=7 Participants
|
—
|
—
|
157 Participants
n=21 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
29 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
—
|
—
|
50 Participants
n=21 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
126 Participants
n=5 Participants
|
89 Participants
n=7 Participants
|
—
|
—
|
215 Participants
n=21 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
—
|
—
|
0 Participants
n=21 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
—
|
—
|
0 Participants
n=21 Participants
|
|
Race (NIH/OMB)
Asian
|
8 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
—
|
—
|
11 Participants
n=21 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
—
|
—
|
0 Participants
n=21 Participants
|
|
Race (NIH/OMB)
Black or African American
|
50 Participants
n=5 Participants
|
29 Participants
n=7 Participants
|
—
|
—
|
79 Participants
n=21 Participants
|
|
Race (NIH/OMB)
White
|
71 Participants
n=5 Participants
|
65 Participants
n=7 Participants
|
—
|
—
|
136 Participants
n=21 Participants
|
|
Race (NIH/OMB)
More than one race
|
26 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
—
|
—
|
39 Participants
n=21 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
—
|
—
|
0 Participants
n=21 Participants
|
PRIMARY outcome
Timeframe: up to 6 monthsPopulation: Data from patient participants only. Data not collected from Oncologists
Number of patient's perceptions that goals of care discussions were increased occurred as measured by GoC qualitative patient survey.
Outcome measures
| Measure |
Patients - GoC Intervention
n=153 Participants
Patients given OncoTalk GoC intervention
GoC intervention: Training of oncologists using OncoTalk to conduct Goals of Care discussions and measure impact on patient satisfaction.
|
Patients - Usual Care
n=110 Participants
Prospective control group where no intervention was given.
|
Oncologist - GoC Intervention
Oncologists trained using OncoTalk to have Goals of Care discussions.
|
Oncologists - Usual Care
Oncologists not trained using OncoTalk to have Goals of Care discussions.
|
|---|---|---|---|---|
|
Number of Participants Who Perceived Increased Goals of Care Discussions
|
43 Participants
|
34 Participants
|
—
|
—
|
PRIMARY outcome
Timeframe: up to 6 monthsPopulation: Data collected for patient participants only
Number of Patient's satisfaction with the discussion of improved goals of care as measured by GoC qualitative patient survey.
Outcome measures
| Measure |
Patients - GoC Intervention
n=153 Participants
Patients given OncoTalk GoC intervention
GoC intervention: Training of oncologists using OncoTalk to conduct Goals of Care discussions and measure impact on patient satisfaction.
|
Patients - Usual Care
n=110 Participants
Prospective control group where no intervention was given.
|
Oncologist - GoC Intervention
Oncologists trained using OncoTalk to have Goals of Care discussions.
|
Oncologists - Usual Care
Oncologists not trained using OncoTalk to have Goals of Care discussions.
|
|---|---|---|---|---|
|
Number of Patients Perception of Improved Goals of Care Discussions
|
70 Participants
|
65 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: up to 6 monthsPopulation: Participants represented are the oncologist's. Data collected for the oncologists only.
Oncologist's communication skills are tested and rated between 1 and 7, with higher number indicating the oncologists were more comfortable in demonstrating communication skills while having the Goals of Care discussion with their patients.
Outcome measures
| Measure |
Patients - GoC Intervention
n=11 Participants
Patients given OncoTalk GoC intervention
GoC intervention: Training of oncologists using OncoTalk to conduct Goals of Care discussions and measure impact on patient satisfaction.
|
Patients - Usual Care
n=11 Participants
Prospective control group where no intervention was given.
|
Oncologist - GoC Intervention
Oncologists trained using OncoTalk to have Goals of Care discussions.
|
Oncologists - Usual Care
Oncologists not trained using OncoTalk to have Goals of Care discussions.
|
|---|---|---|---|---|
|
Communication Skills Training
|
3.7 number of skills tested
Standard Deviation 1.96
|
2.2 number of skills tested
Standard Deviation 1.08
|
—
|
—
|
Adverse Events
Patients - GoC Intervention
Patients - Usual Care
Oncologists - GoC Intervention
Oncologists - Usual Care
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place